This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Aktiebolaget Draco, Other. Active years: 1980-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- 223 75 Lund, SE (1985)
- Lund, SE (1980 - 1989)
Company Filing History:
Years Active: 1980-1989
Title: The Achievements of Inventor Per G Kjellin
Introduction
Per G Kjellin is a notable inventor based in Lund, Sweden, with a prolific portfolio encompassing 8 patents. His innovative contributions primarily focus on pharmaceuticals and treatment methods, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest patents is a groundbreaking "Method and pharmaceutical preparation for treating chronic obstructive airway disease or cardiac disease." This patent emphasizes a method characterized by the administration of specific compounds, including n-propyl, n-butyl, or isobutyl, and their therapeutically acceptable salts. Another significant patent is titled "Process for preparing a purine derivative," which outlines a method for the preparation of enprofylline, further reflecting his dedication to enhancing treatment options in healthcare.
Career Highlights
Throughout his career, Kjellin has worked with prestigious companies, including Aktiebolaget Draco. His work in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to impactful healthcare solutions.
Collaborations
Collaboration has played a vital role in Kjellin's success, notably with esteemed colleagues such as Carl G Persson and Sten Hangkan Bergstrand. Their collective efforts in research and development have led to significant advancements in the fields they have worked in.
Conclusion
Per G Kjellin stands out as a dedicated inventor whose work continues to influence the medical field. His patents serve as a testament to his innovative spirit and collaborative nature, making substantial contributions to the treatment of chronic obstacles in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile